Mentions:
1: Lord Markham (Con - Life peer) Unfortunately, we are all aware of the Wakefield effect on the MMR vaccine. - Speech Link
2: Lord Markham (Con - Life peer) I appreciate the efforts of all noble Lords in doing that. - Speech Link
3: Lord Markham (Con - Life peer) There are a lot of vaccinations, such as the six-in-one ones. - Speech Link
Mentions:
1: Lord Evans of Rainow (Con - Life peer) As I mentioned, 4.5 million people had both their Covid-19 and flu vaccinations at the same time during - Speech Link
2: Lord Allan of Hallam (LD - Life peer) vaccines all the time. - Speech Link
3: Lord Evans of Rainow (Con - Life peer) My Lords, I am most grateful to noble Lords; in closing, I thank all noble Lords for participating in - Speech Link
Asked by: Gavin Williamson (Conservative - South Staffordshire)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps her Department is taking to help increase the provision of covid-19 booster vaccinations to community pharmacies.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
Community pharmacies have been taking part in the COVID-19 vaccination programme since January 2021. NHS England has recently changed the model for procuring COVID-19 vaccination services to an opt-in model. All community pharmacies who applied, and met the minimum requirements, received a contract to deliver COVID-19 vaccinations. This enabled more pharmacies to support the autumn 2023/24 booster campaign, administering COVID-19 vaccinations alongside flu vaccinations, which are also increasingly being administered in these settings.
Apr. 11 2024
Source Page: Travellers urged check on vaccinations to protect against risksFound: Travellers urged check on vaccinations to protect against risks
Asked by: Baroness Ritchie of Downpatrick (Labour - Life peer)
Question to the Department of Health and Social Care:
To ask His Majesty's Government, with reference to declining immunisation rates in the UK, what level of prioritisation the Department of Health and Social Care and the UK Health Security Agency are giving to the adoption of new immunisation programmes with high uptake.
Answered by Lord Markham - Parliamentary Under-Secretary (Department of Health and Social Care)
The introduction and adoption of new immunisation programmes and achieving high uptake across all immunisation programmes remains a high priority for the Government. We achieve high uptake for both life-course and seasonal vaccinations, with over 90% for pre-school diphtheria, tetanus, and pertussis and among the highest in the world for flu vaccination. The NHS COVID-19 vaccination programme has been the biggest vaccine drive in the history of the National Health Service, implementing the largest volume of new vaccines in the shortest time, and repeatedly with boosters. 157.5 million COVID-19 vaccinations were delivered in England from December 2020 to the end of January 2024. However, over the last decade, performance across routine immunisation programmes has been in decline and continued variation in uptake and coverage between different communities reflects wider health inequalities.
In response to these challenges, the NHS vaccination strategy builds on lessons learnt from the pandemic and the success of our routine immunisation programmes. It aims to maximise uptake and coverage of vaccinations across all communities, improving uptake to save more lives.
Mentions:
1: Chris Law (SNP - Dundee West) The world is on the verge of eradicating polio once and for all. - Speech Link
2: Andrew Mitchell (Con - Sutton Coldfield) The UK’s support for childhood vaccinations around the world has played its part, together with institutions - Speech Link
Offer additional covid vaccinations for all staff in education establishments
- Final Signatures: 86
Provide additional covid vaccinations on the NHS for all staff in education establishments - universities, schools, colleges, nurseries etc.
Found: These are all places described by the then prime minister as 'vectors of transmission' for covid.
Jan. 15 2009
Source Page: Measles: don't let your child catch it. [Publicity leaflet] 12 p.Found: Adults are likely to be ill for longer.
Mentions:
1: Christian Wakeford (Lab - Bury South) relationship with the Whips’ Office anymore.I first want to pay tribute to all those who have done so - Speech Link
2: Maria Caulfield (Con - Lewes) in place, but it is another thing to put in long-term, sustainable measures, so it is important that all - Speech Link
3: Maria Caulfield (Con - Lewes) an annual covid vaccine at some point, compared with the spring and autumn roll-outs, but that will all - Speech Link
Asked by: Christopher Chope (Conservative - Christchurch)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, on what date NHS England informed patients receiving the Oxford-AstraZeneca Covid-19 vaccine that there were safety risks of vaccine-induced thrombosis with thrombocytopenia associated with the vaccine.
Answered by Maria Caulfield - Parliamentary Under Secretary of State (Department for Business and Trade) (Minister for Women)
To ensure informed consent was given by patients who received the AstraZeneca COVID-19 vaccine, all vaccination sites were instructed to follow consent guidance in line with the recommendations set out in chapter two of the UK Health Security Agency Green Book on vaccinations and immunisations.
Healthcare organisations administering any COVID-19 vaccinations are responsible for drawing up their own policies for obtaining informed consent, and health professionals overseeing or administering COVID-19 vaccines are responsible for ensuring that valid consent has been obtained. This would normally involve a discussion with the clinician prior to the administration of the vaccine, and individuals will also have had access to guides and patient information leaflets which provided details about the vaccine, how it is administered, possible side effects, and other warnings and precautions to take.
Regarding the very rare adverse events of concurrent thrombosis and thrombocytopenia associated with the AstraZeneca COVID-19 vaccine, NHS England notified healthcare organisations administering the COVID-19 vaccinations immediately following the updated advice from the independent Joint Committee on Vaccination and Immunisation published on 7 April 2021, and then again following updated advice on 7 May 2021. In these updates, sent via system letters, NHS England set out the next steps for healthcare organisations and clinicians, including on the consent process.